{"id":118,"date":"2019-09-12T05:21:07","date_gmt":"2019-09-12T05:21:07","guid":{"rendered":"https:\/\/www.hepafat.com\/?page_id=118"},"modified":"2021-06-25T01:46:05","modified_gmt":"2021-06-25T01:46:05","slug":"research-tool","status":"publish","type":"page","link":"https:\/\/www.hepafat.com\/research-tool\/","title":{"rendered":"Research Tools"},"content":{"rendered":"\t\t
Resonance Health has a suite of ‘for investigational use only’ tools.\u00a0 These tools have been developed inhouse and in accordance with our quality management processes and procedures.\u00a0 These tools do not yet have regulatory clearance and are therefore available for ‘research or investigational use only’.<\/p>
Quantitative Image Analysis available globally in an investigational setting:<\/p>
\u00a0<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t Resonance Health can provide a quantitative assessment of hepatic steatosis of digitised biopsies using stereology. \u00a0Stereology offers multiple key advantages:<\/p> It should be noted that stereology can potentially be applied to the non-biased assessment of other disease related markers, including fibrosis, hepatocyte ballooning, and neutrophil infiltration.\u00a0 In view of the potential for the unbiased assessment of these clinically important biomarkers of liver disease, Resonance Health are currently pursuing methodologies to optimise this process.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\tStereology Services - Liver Biopsy
<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t